We found that DKC1 was significantly upregulated in several cancers, such as lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), and breast invasive carcinoma (BRCA), and exhibited widespread upregulation across different cancer types. Here, DKC1 is linked to cancer.